485 related articles for article (PubMed ID: 15103256)
1. Modulation of chondrocyte production of extracellular inorganic pyrophosphate.
Costello JC; Ryan LM
Curr Opin Rheumatol; 2004 May; 16(3):268-72. PubMed ID: 15103256
[TBL] [Abstract][Full Text] [Related]
2. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
Hirose J; Ryan LM; Masuda I
Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
[TBL] [Abstract][Full Text] [Related]
3. Inorganic pyrophosphate generation by transforming growth factor-beta-1 is mainly dependent on ANK induction by Ras/Raf-1/extracellular signal-regulated kinase pathways in chondrocytes.
Cailotto F; Bianchi A; Sebillaud S; Venkatesan N; Moulin D; Jouzeau JY; Netter P
Arthritis Res Ther; 2007; 9(6):R122. PubMed ID: 18034874
[TBL] [Abstract][Full Text] [Related]
4. Role of the progressive ankylosis gene in cartilage mineralization.
Zaka R; Williams CJ
Curr Opin Rheumatol; 2006 Mar; 18(2):181-6. PubMed ID: 16462526
[TBL] [Abstract][Full Text] [Related]
5. Revisiting spatial distribution and biochemical composition of calcium-containing crystals in human osteoarthritic articular cartilage.
Nguyen C; Bazin D; Daudon M; Chatron-Colliet A; Hannouche D; Bianchi A; Côme D; So A; Busso N; Busso N; Lioté F; Ea HK
Arthritis Res Ther; 2013; 15(5):R103. PubMed ID: 24004678
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease.
Uzuki M; Sawai T; Ryan LM; Rosenthal AK; Masuda I
J Rheumatol; 2014 Jan; 41(1):65-74. PubMed ID: 24293574
[TBL] [Abstract][Full Text] [Related]
7. Synovial fluid inorganic pyrophosphate concentration and nucleotide pyrophosphohydrolase activity in basic calcium phosphate deposition arthropathy and Milwaukee shoulder syndrome.
Rachow JW; Ryan LM; McCarty DJ; Halverson PC
Arthritis Rheum; 1988 Mar; 31(3):408-13. PubMed ID: 2833903
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals.
Caswell A; Guilland-Cumming DF; Hearn PR; McGuire MK; Russell RG
Ann Rheum Dis; 1983 Aug; 42 Suppl 1(Suppl 1):27-37. PubMed ID: 6311118
[No Abstract] [Full Text] [Related]
9. Probenecid inhibits transforming growth factor-beta 1 induced pyrophosphate elaboration by chondrocytes.
Rosenthal AK; Ryan LM
J Rheumatol; 1994 May; 21(5):896-900. PubMed ID: 7520501
[TBL] [Abstract][Full Text] [Related]
10. Calcium input potentiates the transforming growth factor (TGF)-beta1-dependent signaling to promote the export of inorganic pyrophosphate by articular chondrocyte.
Cailotto F; Reboul P; Sebillaud S; Netter P; Jouzeau JY; Bianchi A
J Biol Chem; 2011 Jun; 286(22):19215-28. PubMed ID: 21471198
[TBL] [Abstract][Full Text] [Related]
11. Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition in the knee.
Halverson PB; McCarty DJ
Ann Rheum Dis; 1986 Jul; 45(7):603-5. PubMed ID: 3017246
[TBL] [Abstract][Full Text] [Related]
12. Histologic localization of lipid in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
Ohira T; Ishikawa K; Masuda I; Yokoyama M; Honda I
Arthritis Rheum; 1988 Aug; 31(8):1057-62. PubMed ID: 2457374
[TBL] [Abstract][Full Text] [Related]
13. Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate.
Ryan LM; Rachow JW; McCarty DJ
J Rheumatol; 1991 May; 18(5):716-20. PubMed ID: 1650841
[TBL] [Abstract][Full Text] [Related]
14. Inorganic pyrophosphate (PPI) in pathologic calcification of articular cartilage.
Johnson K; Terkeltaub R
Front Biosci; 2005 Jan; 10():988-97. PubMed ID: 15569637
[TBL] [Abstract][Full Text] [Related]
15. Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition.
Ryan LM; McCarty DJ
Ann Rheum Dis; 1995 Dec; 54(12):939-41. PubMed ID: 8546522
[No Abstract] [Full Text] [Related]
16. Cartilage intermediate layer protein expression in calcium pyrophosphate dihydrate crystal deposition disease.
Yamakawa K; Iwasaki H; Masuda I; Ohjimi Y; Honda I; Iyama K; Shono E; Naito M; Kikuchi M
J Rheumatol; 2002 Aug; 29(8):1746-53. PubMed ID: 12180739
[TBL] [Abstract][Full Text] [Related]
17. Animal models of pathologic calcification.
Masuda I; Hirose J
Curr Opin Rheumatol; 2002 May; 14(3):287-91. PubMed ID: 11981328
[TBL] [Abstract][Full Text] [Related]
18. Ageing increases growth factor-induced inorganic pyrophosphate elaboration by articular cartilage.
Rosenthal AK; Ryan LM
Mech Ageing Dev; 1994 Jul; 75(1):35-44. PubMed ID: 9128752
[TBL] [Abstract][Full Text] [Related]
19. Contribution of calcium-containing crystals to cartilage degradation and synovial inflammation in osteoarthritis.
Liu YZ; Jackson AP; Cosgrove SD
Osteoarthritis Cartilage; 2009 Oct; 17(10):1333-40. PubMed ID: 19447216
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of crystals within the joint.
Oliviero F; Scanu A; Punzi L
Reumatismo; 2012 Jan; 63(4):221-9. PubMed ID: 22303528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
